These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats. Çengelli Ünel Ç; Ayaz B; Aydın Ş; Ulupınar E; Özatik O; Kaygısız B; Yıldırım E; Erol K Turk J Med Sci; 2021 Dec; 51(6):3098-3107. PubMed ID: 34118805 [TBL] [Abstract][Full Text] [Related]
6. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer. Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554 [TBL] [Abstract][Full Text] [Related]
7. Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy. Zhang H; Li Y; de Carvalho-Barbosa M; Kavelaars A; Heijnen CJ; Albrecht PJ; Dougherty PM J Pain; 2016 Jul; 17(7):775-86. PubMed ID: 26979998 [TBL] [Abstract][Full Text] [Related]
8. The Effects of Agomelatine on The Biochemical and Pathological Features of Cisplatin-Induced Peripheral Neuropathy: The First Experimental Study in Rats. Yucetas CS; Ucler N; Cakir T Turk Neurosurg; 2019; 29(6):901-908. PubMed ID: 31573061 [TBL] [Abstract][Full Text] [Related]
9. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206 [TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage. Pollard KJ; Bolon B; Moore MJ Toxicol Sci; 2021 Feb; 180(1):76-88. PubMed ID: 33410881 [TBL] [Abstract][Full Text] [Related]
15. Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice. Acklin S; Zhang M; Du W; Zhao X; Plotkin M; Chang J; Campisi J; Zhou D; Xia F Sci Rep; 2020 Aug; 10(1):14170. PubMed ID: 32843706 [TBL] [Abstract][Full Text] [Related]
16. Piceatannol ameliorates behavioural, biochemical and histological aspects in cisplatin-induced peripheral neuropathy in rats. Wahdan SA; Elsherbiny DA; Azab SS; El-Demerdash E Basic Clin Pharmacol Toxicol; 2021 Dec; 129(6):486-495. PubMed ID: 34390194 [TBL] [Abstract][Full Text] [Related]
17. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin. Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366 [TBL] [Abstract][Full Text] [Related]
18. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy. Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509 [TBL] [Abstract][Full Text] [Related]
19. Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status. Guindon J; Deng L; Fan B; Wager-Miller J; Hohmann AG Mol Pain; 2014 Sep; 10():56. PubMed ID: 25189223 [TBL] [Abstract][Full Text] [Related]
20. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: In vitro and in vivo studies. Marzban E; Alavizadeh SH; Ghiadi M; Khoshangosht M; Khashayarmanesh Z; Abbasi A; Jaafari MR Colloids Surf B Biointerfaces; 2015 Dec; 136():885-91. PubMed ID: 26547316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]